{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:53:17Z","timestamp":1775065997002,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2047-9158-3-7","type":"journal-article","created":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T12:04:02Z","timestamp":1395317042000},"source":"Crossref","is-referenced-by-count":19,"title":["Epigenetic modifications of chronic hypoxia-mediated neurodegeneration in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"3","author":[{"given":"Hui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,20]]},"reference":[{"key":"57_CR1","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/S0140-6736(13)60221-4","volume":"381","author":"KY Chan","year":"2013","unstructured":"Chan KY, Wang W, Wu JJ, Liu L, Theodoratou E, Car J, Middleton L, Russ TC, Deary IJ, Campbell H, Wang W, Rudan I: Epidemiology of Alzheimer\u2019s disease and other forms of dementia in China, 1990\u20132010: a systematic review and analysis. Lancet 2013, 381: 2016-2023. 10.1016\/S0140-6736(13)60221-4","journal-title":"Lancet"},{"key":"57_CR2","doi-asserted-by":"publisher","first-page":"14946","DOI":"10.1523\/JNEUROSCI.4305-10.2010","volume":"30","author":"SW Pimplikar","year":"2010","unstructured":"Pimplikar SW, Nixon RA, Robakis NK, Shen J, Tsai LH: Amyloid-independent mechanisms in Alzheimer\u2019s disease pathogenesis. J Neurosci 2010, 30: 14946-14954. 10.1523\/JNEUROSCI.4305-10.2010","journal-title":"J Neurosci"},{"key":"57_CR3","first-page":"347","volume":"2","author":"RH Swerdlow","year":"2007","unstructured":"Swerdlow RH: Pathogenesis of Alzheimer\u2019s disease. Clin Interv Aging 2007, 2: 347-359.","journal-title":"Clin Interv Aging"},{"key":"57_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"M Goedert","year":"2006","unstructured":"Goedert M, Spillantini MG: A century of Alzheimer\u2019s disease. Science 2006, 314: 777-781. 10.1126\/science.1132814","journal-title":"Science"},{"key":"57_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","volume":"68","author":"L Bertram","year":"2010","unstructured":"Bertram L, Lill CM, Tanzi RE: The genetics of Alzheimer disease: back to the future. Neuron 2010, 68: 270-281. 10.1016\/j.neuron.2010.10.013","journal-title":"Neuron"},{"key":"57_CR6","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 2009, 41: 1088-1093. 10.1038\/ng.440","journal-title":"Nat Genet"},{"key":"57_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V: Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet 2011, 43: 429-435. 10.1038\/ng.803","journal-title":"Nat Genet"},{"key":"57_CR8","volume-title":"Int J Alzheimers Dis","author":"L Chouliaras","year":"2010","unstructured":"Chouliaras L, Sierksma AS, Kenis G, Prickaerts J, Lemmens MA, Brasnjevic I, van Donkelaar EL, Martinez-Martinez P, Losen M, De Baets MH, Kholod N, Van Leeuwen F, Hof PR, Van Os J, Steinbusch HWM, Van den Hove DLA, Rutten BPF: Gene-environment interaction research and transgenic mouse models of Alzheimer\u2019s disease. Int J Alzheimers Dis 2010., 2010: doi: 10.4061\/2010\/859101"},{"key":"57_CR9","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/mp.2009.82","volume":"14","author":"DK Lahiri","year":"2009","unstructured":"Lahiri DK, Maloney B, Zawia NH: The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry 2009, 14: 992-1003. 10.1038\/mp.2009.82","journal-title":"Mol Psychiatry"},{"key":"57_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10522-008-9162-6","volume":"9","author":"DK Lahiri","year":"2008","unstructured":"Lahiri DK, Zawia NH, Greig NH, Sambamurti K, Maloney B: Early-life events may trigger biochemical pathways for Alzheimer\u2019s disease: the \u201cLEARn\u201d model. Biogerontology 2008, 9: 375-379. 10.1007\/s10522-008-9162-6","journal-title":"Biogerontology"},{"key":"57_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jalz.2009.01.019","volume":"5","author":"MC Carrillo","year":"2009","unstructured":"Carrillo MC, Blackwell A, Hampel H, Lindborg J, Sperling R, Schenk D, Sevigny JJ, Ferris S, Bennett DA, Craft S, Timothy H, Klunk W: Early risk assessment for Alzheimer\u2019s disease. Alzheimers Dement 2009, 5: 182-196. 10.1016\/j.jalz.2009.01.019","journal-title":"Alzheimers Dement"},{"key":"57_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/jnnp.74.7.857","volume":"74","author":"S Fleminger","year":"2003","unstructured":"Fleminger S, Oliver D, Lovestone S, Rabe-Hesketh S, Giora A: Head injury as a risk factor for Alzheimer\u2019s disease: the evidence 10\u00a0years on; a partial replication. J Neurol Neurosurg Psychiatry 2003, 74: 857-862. 10.1136\/jnnp.74.7.857","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"57_CR13","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.neubiorev.2012.02.013","volume":"36","author":"TM Sivanandam","year":"2012","unstructured":"Sivanandam TM, Thakur MK: Traumatic brain injury: a risk factor for Alzheimer\u2019s disease. Neurosci Biobehav Rev 2012, 36: 1376-1381. 10.1016\/j.neubiorev.2012.02.013","journal-title":"Neurosci Biobehav Rev"},{"key":"57_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMoa011613","volume":"346","author":"S Seshadri","year":"2002","unstructured":"Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D\u2019Agostino RB, Wilson PW, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease. N Engl J Med 2002, 346: 476-483. 10.1056\/NEJMoa011613","journal-title":"N Engl J Med"},{"key":"57_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.expneurol.2009.07.033","volume":"223","author":"X Zhang","year":"2010","unstructured":"Zhang X, Le W: Pathological role of hypoxia in Alzheimer\u2019s disease. Exp Neurol 2010, 223: 299-303. 10.1016\/j.expneurol.2009.07.033","journal-title":"Exp Neurol"},{"key":"57_CR16","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/S0002-9440(10)63747-9","volume":"164","author":"C Michiels","year":"2004","unstructured":"Michiels C: Physiological and pathological responses to hypoxia. Am J Pathol 2004, 164: 1875-1882. 10.1016\/S0002-9440(10)63747-9","journal-title":"Am J Pathol"},{"key":"57_CR17","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1161\/01.STR.0000127810.92616.78","volume":"35","author":"CS Ivan","year":"2004","unstructured":"Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, Wolf PA: Dementia after stroke the Framingham study. Stroke 2004, 35: 1264-1268. 10.1161\/01.STR.0000127810.92616.78","journal-title":"Stroke"},{"key":"57_CR18","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/STROKEAHA.109.559880","volume":"41","author":"GM Savva","year":"2010","unstructured":"Savva GM, Stephan BC: Epidemiological studies of the effect of stroke on incident dementia a systematic review. Stroke 2010, 41: e41-e46. 10.1161\/STROKEAHA.109.559880","journal-title":"Stroke"},{"key":"57_CR19","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1161\/01.STR.0000217971.88034.e9","volume":"37","author":"S Ukraintseva","year":"2006","unstructured":"Ukraintseva S, Sloan F, Arbeev K, Yashin A: Increasing rates of dementia at time of declining mortality from stroke. Stroke 2006, 37: 1155-1159. 10.1161\/01.STR.0000217971.88034.e9","journal-title":"Stroke"},{"key":"57_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/jnnp.57.4.419","volume":"57","author":"GW Roberts","year":"1994","unstructured":"Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI: Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 1994, 57: 419-425. 10.1136\/jnnp.57.4.419","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"57_CR21","doi-asserted-by":"publisher","first-page":"e28263","DOI":"10.1371\/journal.pone.0028263","volume":"6","author":"H Zetterberg","year":"2011","unstructured":"Zetterberg H, M\u00f6rtberg E, Song L, Chang L, Provuncher GK, Patel PP, Ferrell E, Fournier DR, Kan CW, Campbell TG: Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid \u03b2 levels in humans. PLoS One 2011, 6: e28263. 10.1371\/journal.pone.0028263","journal-title":"PLoS One"},{"key":"57_CR22","first-page":"613","volume":"306","author":"AML Kristine Yaffe","year":"2011","unstructured":"Kristine Yaffe AML, Harrison SL, Redline S, Spira AP, Ensrud KE, Ancoli-Israel S, Stone KL: Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 2011, 306: 613-619.","journal-title":"JAMA"},{"key":"57_CR23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1212\/WNL.0b013e31829e701d","volume":"81","author":"CH Hong","year":"2013","unstructured":"Hong CH, Falvey C, Harris TB, Simonsick EM, Satterfield S, Ferrucci L, Metti AL, Patel KV, Yaffe K: Anemia and risk of dementia in older adults: findings from the Health ABC study. Neurology 2013, 81: 528-533. 10.1212\/WNL.0b013e31829e701d","journal-title":"Neurology"},{"key":"57_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbrc.2011.05.101","volume":"410","author":"J Li","year":"2011","unstructured":"Li J, Dong Z, Liu B, Zhuo Y, Sun X, Yang Z, Ge J, Tan Z: Hypoxia induces beta-amyloid in association with death of RGC-5 cells in culture. Biochem Biophys Res Commun 2011, 410: 40-44. 10.1016\/j.bbrc.2011.05.101","journal-title":"Biochem Biophys Res Commun"},{"key":"57_CR25","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.neurobiolaging.2007.10.011","volume":"30","author":"L Li","year":"2009","unstructured":"Li L, Zhang X, Yang D, Luo G, Chen S, Le W: Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP. Neurobiol Aging 2009, 30: 1091-1098. 10.1016\/j.neurobiolaging.2007.10.011","journal-title":"Neurobiol Aging"},{"key":"57_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.neurobiolaging.2012.06.012","volume":"34","author":"X Zhang","year":"2013","unstructured":"Zhang X, Li L, Zhang X, Xie W, Li L, Yang D, Heng X, Du Y, Doody RS, Le W: Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer\u2019s disease neuropathology in APPSwe\/PS1A246E transgenic mice. Neurobiol Aging 2013, 34: 663-678. 10.1016\/j.neurobiolaging.2012.06.012","journal-title":"Neurobiol Aging"},{"key":"57_CR27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/cns.12151","volume":"19","author":"CY Wang","year":"2013","unstructured":"Wang CY, Xie JW, Wang T, Xu Y, Cai JH, Wang X, Zhao BL, An L, Wang ZY: Hypoxia-triggered m-calpain activation evokes endoplasmic reticulum stress and neuropathogenesis in a transgenic mouse model of Alzheimer\u2019s disease. CNS Neurosci Ther 2013, 19: 820-833.","journal-title":"CNS Neurosci Ther"},{"key":"57_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1113\/jphysiol.2006.111203","volume":"575","author":"HA Pearson","year":"2006","unstructured":"Pearson HA, Peers C: Physiological roles for amyloid beta peptides. J Physiol 2006, 575: 5-10. 10.1113\/jphysiol.2006.111203","journal-title":"J Physiol"},{"key":"57_CR29","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1007\/s00018-008-8112-4","volume":"65","author":"E Malito","year":"2008","unstructured":"Malito E, Hulse RE, Tang W-J: Amyloid \u03b2-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin. Cell Mol Life Sci 2008, 65: 2574-2585. 10.1007\/s00018-008-8112-4","journal-title":"Cell Mol Life Sci"},{"key":"57_CR30","doi-asserted-by":"publisher","first-page":"18727","DOI":"10.1073\/pnas.0606298103","volume":"103","author":"X Sun","year":"2006","unstructured":"Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, Staufenbiel M, Huang LE, Song W: Hypoxia facilitates Alzheimer\u2019s disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci U S A 2006, 103: 18727-18732. 10.1073\/pnas.0606298103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"57_CR31","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1096\/fj.06-5839fje","volume":"20","author":"R Wang","year":"2006","unstructured":"Wang R, Zhang YW, Zhang X, Liu R, Zhang X, Hong S, Xia K, Xia J, Zhang Z, Xu H: Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia. FASEB J 2006, 20: 1275-1277. 10.1096\/fj.06-5839fje","journal-title":"FASEB J"},{"key":"57_CR32","doi-asserted-by":"publisher","first-page":"e19229","DOI":"10.1371\/journal.pone.0019229","volume":"6","author":"Z Wang","year":"2011","unstructured":"Wang Z, Yang D, Zhang X, Li T, Li J, Tang Y, Le W: Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons. PLoS One 2011, 6: e19229. 10.1371\/journal.pone.0019229","journal-title":"PLoS One"},{"key":"57_CR33","doi-asserted-by":"publisher","first-page":"10873","DOI":"10.1074\/jbc.M608856200","volume":"282","author":"X Zhang","year":"2007","unstructured":"Zhang X, Zhou K, Wang R, Cui J, Lipton SA, Liao FF, Xu H, Zhang YW: Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem 2007, 282: 10873-10880. 10.1074\/jbc.M608856200","journal-title":"J Biol Chem"},{"key":"57_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.brainres.2006.05.008","volume":"1099","author":"AJ Marshall","year":"2006","unstructured":"Marshall AJ, Rattray M, Vaughan PF: Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative \u03b1-secretases, ADAM10 and TACE, without altering their mRNA levels. Brain Res 2006, 1099: 18-24. 10.1016\/j.brainres.2006.05.008","journal-title":"Brain Res"},{"key":"57_CR35","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1046\/j.1471-4159.2002.01236.x","volume":"83","author":"NJ Webster","year":"2002","unstructured":"Webster NJ, Green KN, Peers C, Vaughan PF: Altered processing of amyloid precursor protein in the human neuroblastoma SH SY5Y by chronic hypoxia. J Neurochem 2002, 83: 1262-1271. 10.1046\/j.1471-4159.2002.01236.x","journal-title":"J Neurochem"},{"key":"57_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1101\/gad.12.2.149","volume":"12","author":"NV Iyer","year":"1998","unstructured":"Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Aimee YY: Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1\u03b1. Genes Dev 1998, 12: 149-162. 10.1101\/gad.12.2.149","journal-title":"Genes Dev"},{"key":"57_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2353\/ajpath.2007.070105","volume":"171","author":"W Farris","year":"2007","unstructured":"Farris W, Sch\u00fctz SG, Cirrito JR, Shankar GM, Sun X, George A, Leissring MA, Walsh DM, Qiu WQ, Holtzman DM: Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. Am J Pathol 2007, 171: 241-251. 10.2353\/ajpath.2007.070105","journal-title":"Am J Pathol"},{"key":"57_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0304-3940(03)00030-2","volume":"339","author":"J Apelt","year":"2003","unstructured":"Apelt J, Ach K, Schliebs R: Aging-related down-regulation of neprilysin, a putative \u03b2-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of \u03b2-amyloid plaques. Neurosci Lett 2003, 339: 183-186. 10.1016\/S0304-3940(03)00030-2","journal-title":"Neurosci Lett"},{"key":"57_CR39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.neurobiolaging.2004.06.013","volume":"26","author":"A Caccamo","year":"2005","unstructured":"Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM: Age-and region-dependent alterations in A\u03b2-degrading enzymes: implications for A\u03b2-induced disorders. Neurobiol Aging 2005, 26: 645-654. 10.1016\/j.neurobiolaging.2004.06.013","journal-title":"Neurobiol Aging"},{"key":"57_CR40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/01.jnen.0000182981.02355.10","volume":"64","author":"D-S Wang","year":"2005","unstructured":"Wang D-S, Lipton RB, Katz MJ, Davies P, Buschke H, Kuslansky G, Verghese J, Younkin SG, Eckman C, Dickson DW: Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging. J Neuropathol Exp Neurol 2005, 64: 378-385.","journal-title":"J Neuropathol Exp Neurol"},{"key":"57_CR41","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1016\/j.febslet.2005.09.054","volume":"579","author":"R Russo","year":"2005","unstructured":"Russo R, Borghi R, Markesbery W, Tabaton M, Piccini A: Neprylisin decreases uniformly in Alzheimer\u2019s disease and in normal aging. FEBS Lett 2005, 579: 6027-6030. 10.1016\/j.febslet.2005.09.054","journal-title":"FEBS Lett"},{"key":"57_CR42","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jnen\/61.10.849","volume":"61","author":"M Carpentier","year":"2002","unstructured":"Carpentier M, Robitaille Y, DesGroseillers L, Boileau G, Marcinkiewicz M: Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy. J Neuropathol Exp Neurol 2002, 61: 849-856.","journal-title":"J Neuropathol Exp Neurol"},{"key":"57_CR43","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s11064-007-9349-2","volume":"32","author":"L Fisk","year":"2007","unstructured":"Fisk L, Nalivaeva NN, Boyle JP, Peers CS, Turner AJ: Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem Res 2007, 32: 1741-1748. 10.1007\/s11064-007-9349-2","journal-title":"Neurochem Res"},{"key":"57_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1196\/annals.1332.002","volume":"1035","author":"NN Nalivaevaa","year":"2004","unstructured":"Nalivaevaa NN, Fisk L, Kochkina EG, Plesneva SA, Zhuravin IA, Babusikova E, Dobrota D, Turner AJ: Effect of hypoxia\/ischemia and hypoxic preconditioning\/reperfusion on expression of some amyloid degrading enzymes. Ann N Y Acad Sci 2004, 1035: 21-33. 10.1196\/annals.1332.002","journal-title":"Ann N Y Acad Sci"},{"key":"57_CR45","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch R, Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003, 33: 245-254. 10.1038\/ng1089","journal-title":"Nat Genet"},{"key":"57_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1503\/cmaj.050774","volume":"174","author":"D Rodenhiser","year":"2006","unstructured":"Rodenhiser D, Mann M: Epigenetics and human disease: translating basic biology into clinical applications. Can Med Assoc J 2006, 174: 341-348. 10.1503\/cmaj.050774","journal-title":"Can Med Assoc J"},{"key":"57_CR47","doi-asserted-by":"publisher","first-page":"e2698","DOI":"10.1371\/journal.pone.0002698","volume":"3","author":"S-C Wang","year":"2008","unstructured":"Wang S-C, Oelze B, Schumacher A: Age-specific epigenetic drift in late-onset Alzheimer\u2019s disease. PLoS One 2008, 3: e2698. 10.1371\/journal.pone.0002698","journal-title":"PLoS One"},{"key":"57_CR48","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","volume":"13","author":"PA Jones","year":"2012","unstructured":"Jones PA: Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012, 13: 484-492. 10.1038\/nrg3230","journal-title":"Nat Rev Genet"},{"key":"57_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.mcn.2004.09.007","volume":"28","author":"A Fuso","year":"2005","unstructured":"Fuso A, Seminara L, Cavallaro RA, D\u2019Anselmi F, Scarpa S: S-adenosylmethionine\/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol Cell Neurosci 2005, 28: 195-204. 10.1016\/j.mcn.2004.09.007","journal-title":"Mol Cell Neurosci"},{"key":"57_CR50","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF02736773","volume":"6","author":"L Roger","year":"1995","unstructured":"Roger L, West JML, Maroun LE: Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer\u2019s disease patient. J Mol Neurosci 1995, 6: 141-146. 10.1007\/BF02736773","journal-title":"J Mol Neurosci"},{"key":"57_CR51","doi-asserted-by":"publisher","first-page":"e6617","DOI":"10.1371\/journal.pone.0006617","volume":"4","author":"D Mastroeni","year":"2009","unstructured":"Mastroeni D, McKee A, Grover A, Rogers J, Coleman PD: Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer\u2019s disease. PLoS One 2009, 4: e6617. 10.1371\/journal.pone.0006617","journal-title":"PLoS One"},{"key":"57_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4161\/epi.2.2.4613","volume":"2","author":"S Shahrzad","year":"2007","unstructured":"Shahrzad S, Bertrand K, Minhas K, Coomber B: Induction of DNA hypomethylation by tumor hypoxia. Epigenetics 2007, 2: 119-125. 10.4161\/epi.2.2.4613","journal-title":"Epigenetics"},{"key":"57_CR53","doi-asserted-by":"publisher","first-page":"e77859","DOI":"10.1371\/journal.pone.0077859","volume":"8","author":"I Hartley","year":"2013","unstructured":"Hartley I, Elkhoury FF, Shin JH, Xie B, Gu X, Gao Y, Zhou D, Haddad GG: Long-lasting changes in DNA methylation following short-term hypoxic exposure in primary hippocampal neuronal cultures. PLoS One 2013, 8: e77859. 10.1371\/journal.pone.0077859","journal-title":"PLoS One"},{"key":"57_CR54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbrc.2008.10.173","volume":"378","author":"K-L Chen","year":"2009","unstructured":"Chen K-L, Wang SS-S, Yang Y-Y, Yuan R-Y, Chen R-M, Hu C-J: The epigenetic effects of amyloid-\u03b2\u2009<\u2009sub\u2009>\u20091\u201340<\/sub\u2009>\u2009on global DNA and neprilysin genes in murine cerebral endothelial cells. Biochem Biophys Res Commun 2009, 378: 57-61. 10.1016\/j.bbrc.2008.10.173","journal-title":"Biochem Biophys Res Commun"},{"key":"57_CR55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/embor.2008.222","volume":"10","author":"ND Belyaev","year":"2008","unstructured":"Belyaev ND, Nalivaeva NN, Makova NZ, Turner AJ: Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep 2008, 10: 94-100.","journal-title":"EMBO Rep"},{"key":"57_CR56","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","volume":"9","author":"F Mangialasche","year":"2010","unstructured":"Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M: Alzheimer\u2019s disease: clinical trials and drug development. Lancet Neurol 2010, 9: 702-716. 10.1016\/S1474-4422(10)70119-8","journal-title":"Lancet Neurol"},{"key":"57_CR57","doi-asserted-by":"publisher","first-page":"649","DOI":"10.5483\/BMBRep.2010.43.10.649","volume":"43","author":"JH Lee","year":"2010","unstructured":"Lee JH: Mini review: epigenetic modification is linked to alzheimers disease: is it a maker or a marker? BMB Rep 2010, 43: 649-655. 10.5483\/BMBRep.2010.43.10.649","journal-title":"BMB Rep"},{"issue":"1","key":"57_CR58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pharmthera.2013.03.010","volume":"139","author":"L Adwan","year":"2013","unstructured":"Adwan L, Zawia NH: Epigenetics: a novel therapeutic approach for the treatment of Alzheimer\u2019s disease. Pharmacol Ther 2013, 139(1):41-50. 10.1016\/j.pharmthera.2013.03.010","journal-title":"Pharmacol Ther"},{"key":"57_CR59","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/j.1365-2125.2012.04443.x","volume":"75","author":"F Caraci","year":"2012","unstructured":"Caraci F, Leggio GM, Drago F, Salomone S: Epigenetic drugs for Alzheimer\u2019s disease: hopes and challenges. Br J Clin Pharmacol 2012, 75: 1154-1155.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"57_CR60","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.arr.2013.05.003","volume":"12","author":"J Wang","year":"2013","unstructured":"Wang J, Yu J-T, Tan M-S, Jiang T, Tan L: Epigenetic mechanisms in Alzheimer\u2019s disease: Implications for pathogenesis and therapy. Ageing Res Rev 2013, 12(4):1024-41. 10.1016\/j.arr.2013.05.003","journal-title":"Ageing Res Rev"},{"key":"57_CR61","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1515\/bmc-2013-0012","volume":"4","author":"M Cuadrado-Tejedor","year":"2013","unstructured":"Cuadrado-Tejedor M, Oyarzabal J, Lucas MP, Franco R, Garc\u00eda-Osta A: Epigenetic drugs in Alzheimer\u2019s disease. Biomolecular Concepts 2013, 4: 433-445.","journal-title":"Biomolecular Concepts"},{"key":"57_CR62","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/j.1365-2125.2012.04444.x","volume":"75","author":"J Peedicayil","year":"2012","unstructured":"Peedicayil J: Epigenetic drugs for Alzheimer\u2019s disease. Br J Clin Pharmacol 2012, 75: 1152-1153.","journal-title":"Br J Clin Pharmacol"},{"key":"57_CR63","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1874467210902010095","volume":"2","author":"B Monti","year":"2009","unstructured":"Monti B, Polazzi E, Contestabile A: Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol 2009, 2: 95-109. 10.2174\/1874467210902010095","journal-title":"Curr Mol Pharmacol"},{"key":"57_CR64","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.tips.2009.07.002","volume":"30","author":"NN Nalivaeva","year":"2009","unstructured":"Nalivaeva NN, Belyaev ND, Turner AJ: Sodium valproate: an old drug with new roles. Trends Pharmacol Sci 2009, 30: 509-514. 10.1016\/j.tips.2009.07.002","journal-title":"Trends Pharmacol Sci"},{"key":"57_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brainresbull.2009.09.003","volume":"81","author":"X-Z Zhang","year":"2010","unstructured":"Zhang X-Z, Li X-J, Zhang H-Y: Valproic acid as a promising agent to combat Alzheimer\u2019s disease. Brain Res Bull 2010, 81: 3-6. 10.1016\/j.brainresbull.2009.09.003","journal-title":"Brain Res Bull"},{"key":"57_CR66","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1084\/jem.20081588","volume":"205","author":"H Qing","year":"2008","unstructured":"Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, Cai F, Zhang Z, Wei S, Sun X, Chen C-H: Valproic acid inhibits A\u03b2 production, neuritic plaque formation, and behavioral deficits in Alzheimer\u2019s disease mouse models. J Exp Med 2008, 205: 2781-2789. 10.1084\/jem.20081588","journal-title":"J Exp Med"},{"key":"57_CR67","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/cns.12186","volume":"20","author":"Z Wang","year":"2013","unstructured":"Wang Z, Zhang XJ, Li T, Li J, Tang Y, Le W: Valproic acid reduces neuritic plaque formation and improves learning deficits in APPSwe\/PS1A246E transgenic mice via preventing the prenatal hypoxia induced down regulation of neprilysin. CNS Neurosci Ther 2013, 20: 209-217.","journal-title":"CNS Neurosci Ther"},{"key":"57_CR68","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s12031-011-9644-x","volume":"46","author":"NN Nalivaeva","year":"2012","unstructured":"Nalivaeva NN, Belyaev ND, Lewis DI, Pickles AR, Makova NZ, Bagrova DI, Dubrovskaya NM, Plesneva SA, Zhuravin IA, Turner AJ: Effect of sodium valproate administration on brain neprilysin expression and memory in rats. J Mol Neurosci 2012, 46: 569-577. 10.1007\/s12031-011-9644-x","journal-title":"J Mol Neurosci"},{"key":"57_CR69","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12640-013-9379-2","volume":"24","author":"MA Daulatzai","year":"2013","unstructured":"Daulatzai MA: Death by a thousand cuts in Alzheimer\u2019s disease: hypoxia\u2014the prodrome. Neurotox Res 2013, 24: 216-243. 10.1007\/s12640-013-9379-2","journal-title":"Neurotox Res"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2047-9158-3-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T05:56:41Z","timestamp":1716616601000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/2047-9158-3-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,20]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1186\/2047-9158-3-7","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,20]]},"article-number":"7"}}